Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats

被引:23
作者
Zhang, Zhengyu [1 ]
Tachikawa, Masanori [1 ]
Uchida, Yasuo [1 ]
Terasaki, Tetsuya [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi 9808578, Japan
关键词
blood-cerebrospinal fluid barrier; blood-arachnoid barrier; pharmacokinetics; organic anion transporters; oat1; oat3; leptomeninges; BLOOD-BRAIN-BARRIER; TARGETED ABSOLUTE PROTEOMICS; CANCER RESISTANCE PROTEIN; CHOROID-PLEXUS; P-GLYCOPROTEIN; FUNCTIONAL-CHARACTERIZATION; QUANTITATIVE ATLAS; JUNCTION PROTEINS; EXPRESSION LEVELS; SURROGATE;
D O I
10.1021/acs.molpharmaceut.7b00852
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although arachnoid mater epithelial cells form the blood-arachnoid barrier (BAB), acting as a blood-CSF interface, it has been generally considered that the BAB is impermeable to water-soluble substances and plays a largely passive role. Here, we aimed to clarify the function of transporters at the BAB in regulating CSF clearance of water-soluble organic anion drugs based on quantitative targeted absolute proteomics (QTAP) and in vivo analyses. Protein expression levels of 61 molecules, including 19 ATP-binding-cassette (ABC) transporters and 32 solute-carrier (SLC) transporters, were measured in plasma membrane fraction of rat leptomeninges using QTAP. Thirty-three proteins were detected; others were under the quantification limits. Expression levels of multidrug resistance protein 1 (Mdr1a/P-gp/Abcb1a) and breast cancer resistance protein (Bcrp/Abcg2) were 16.6 and 3.27 fmol/mu g protein (51.9- and 9.82-fold greater than in choroid plexus, respectively). Among those organic anion transporters detected only at leptomeninges, not choroid plexus, organic anion transporter 1 (oat1/Slc22a6) showed the greatest expression (2.73 fmol/mu g protein). On the other hand, the protein expression level of oat3 at leptomeninges was 6.65 fmol/mu g protein, and the difference from choroid plexus was within two-fold. To investigate oat1's role, we injected para-aminohippuric acid (PAH) with or without oat1 inhibitors into cisterna magna (to minimize the contribution of choroid plexus function) of rats. A bulk flow marker, FITC-inulin, was not taken up from CSF up to 15 min, whereas uptake clearance of PAH was 26.5 mu L/min. PAH uptake was completely blocked by 3 mM cephalothin (inhibits both oat1 and oat3), while 17% of PAH uptake was inhibited by 0.2 mM cephalothin (selectively inhibits oat3). These results indicate that oat1 and oat3 at the BAB provide a distinct clearance pathway of organic anion drugs from CSF independently of choroid plexus.
引用
收藏
页码:911 / 922
页数:12
相关论文
共 57 条
[11]   Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo [J].
Hughes, S ;
Chan-Ling, T .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (08) :2795-2806
[12]   A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β [J].
Iliff, Jeffrey J. ;
Wang, Minghuan ;
Liao, Yonghong ;
Plogg, Benjamin A. ;
Peng, Weiguo ;
Gundersen, Georg A. ;
Benveniste, Helene ;
Vates, G. Edward ;
Deane, Rashid ;
Goldman, Steven A. ;
Nagelhus, Erlend A. ;
Nedergaard, Maiken .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (147)
[13]   Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: In comparison with rOAT1 [J].
Jung, KY ;
Takeda, M ;
Shimoda, M ;
Narikawa, S ;
Tojo, A ;
Kim, DK ;
Chairoungdua, A ;
Choi, BK ;
Kusuhara, H ;
Sugiyama, Y ;
Sekine, T ;
Endou, H .
LIFE SCIENCES, 2002, 70 (16) :1861-1874
[14]   Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of Nelfinavir into the brain but not into the cerebrospinal fluid [J].
Kaddoumi, Amal ;
Choi, Sung-Up ;
Kinman, Loren ;
Whittington, Dale ;
Tsai, Che-Chung ;
Ho, Rodney J. Y. ;
Anderson, Bradley D. ;
Unadkat, Jashvant D. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) :1459-1462
[15]   Quantitative atlas of membrane transporter proteins:: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria [J].
Kamiie, Junichi ;
Ohtsuki, Sumio ;
Iwase, Ryo ;
Unine, Ken ;
Katsukura, Yuki ;
Yanai, Kazunari ;
Sekine, Yumi ;
Uchida, Yasuo ;
Ito, Shingo ;
Terasaki, Tetsuya .
PHARMACEUTICAL RESEARCH, 2008, 25 (06) :1469-1483
[16]   Quantitative Evaluation of the Impact of Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier on the Predictability of the Unbound Concentrations of Drugs in the Brain Using Cerebrospinal Fluid Concentration as a Surrogate [J].
Kodaira, Hiroshi ;
Kusuhara, Hiroyuki ;
Fujita, Takuya ;
Ushiki, Junko ;
Fuse, Eiichi ;
Sugiyama, Yuichi .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (03) :935-944
[17]   Chronic subdural haematoma: modern management and emerging therapies [J].
Kolias, Angelos G. ;
Chari, Aswin ;
Santarius, Thomas ;
Hutchinson, Peter J. .
NATURE REVIEWS NEUROLOGY, 2014, 10 (10) :570-578
[18]   Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain [J].
Kusuhara, H ;
Sekine, T ;
Utsunomiya-Tate, N ;
Tsuda, M ;
Kojima, R ;
Cha, SH ;
Sugiyama, Y ;
Kanai, Y ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13675-13680
[19]   CSF as a surrogate for assessing CNS exposure: An industrial perspective [J].
Lin, Jiunn H. .
CURRENT DRUG METABOLISM, 2008, 9 (01) :46-59
[20]   Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration [J].
Liu, Xingrong ;
Smith, Bill J. ;
Chen, Cuiping ;
Callegari, Ernesto ;
Becker, Stacey L. ;
Chen, Xi ;
Cianfrogna, Julie ;
Doran, Angela C. ;
Doran, Shawn D. ;
Gibbs, John P. ;
Hosea, Natilie ;
Liu, Jianhua ;
Nelson, Frederick R. ;
Szewc, Mark A. ;
Van Deusen, Jeffrey .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) :1443-1447